Biotech Hemp Ingredient Market Size, Share, Trends & Competitive Analysis By Type: Cannabidiol (CBD), Cannabigerol (CBG) By Application: Food & Beverages, Pharmaceuticals By End-User, By Regions, and Industry Forecast, Global Report 2026-2033

The global Biotech Hemp Ingredient Market size was valued at USD 0.9 billion in 2025 and is projected to expand at a compound annual growth rate (CAGR) of 26% during the forecast period, reaching a value of USD 4.4 billion by 2033.

The Biotech Hemp Ingredient Market Research Report by Future Data Stats delivers a comprehensive and strategic perspective on the evolving global market landscape. Built on an extensive foundation of historical data from 2022 to 2024, the report identifies key trends, evolving growth patterns, and influential market dynamics shaping the industry’s trajectory. Anchored in 2025 as the base year, the study provides an in-depth evaluation of consumer behavior, competitive frameworks, and regulatory developments, offering a clear understanding of the factors driving market transformation.

Looking ahead, the report presents a robust forecast from 2026 to 2035, supported by advanced analytical methodologies and data-driven modeling. It outlines the projected growth outlook, pinpoints emerging opportunities, and assesses potential challenges to support well-informed strategic planning and investment decisions. Designed for business leaders, investors, policymakers, and industry stakeholders, this report serves as a valuable decision-making tool—equipping organizations with actionable intelligence to navigate complexity, capitalize on growth potential, and maintain a competitive edge in a dynamic market environment.

MARKET OVERVIEW:

The Biotech Hemp Ingredient Market focuses on developing and supplying hemp-based products that enhance health, wellness, and sustainability. Companies drive innovation by extracting bioactive compounds from hemp to create functional ingredients for food, cosmetics, pharmaceuticals, and nutraceuticals. Researchers explore hemp’s natural properties to deliver high-quality, safe, and effective solutions for various industries. This market serves a growing demand for natural and eco-friendly alternatives. Businesses invest in improving production processes, expanding applications, and meeting regulatory standards. By addressing consumer needs, the market promotes healthier lifestyles and environmentally responsible practices worldwide.

MARKET DYNAMICS:

Rising consumer demand for natural and sustainable products drives growth in the Biotech Hemp Ingredient Market. Companies innovate by developing high-quality hemp extracts for food, cosmetics, and pharmaceuticals, expanding their reach globally. However, strict regulations and high production costs can limit market growth. At the same time, new research and untapped applications create opportunities for businesses to introduce innovative, eco-friendly solutions.

The Biotech Hemp Ingredient Market is rapidly evolving, driven by innovative research and growing consumer demand. Companies are exploring new applications of hemp in various sectors, including health and wellness, cosmetics, and food. As regulations become more favorable, businesses anticipate expanded opportunities, allowing them to harness hemp’s potential while contributing to sustainable practices and enhancing product offerings in diverse industries.

BIOTECH HEMP INGREDIENT MARKET SEGMENTATION ANALYSIS

BY TYPE:

By type, the biotech hemp ingredient market is dominated by CBD due to its wide therapeutic applications, established regulatory acceptance, and strong consumer demand in wellness, skincare, and pharmaceutical formulations. CBG and CBN are emerging rapidly as brands explore minor cannabinoids for targeted benefits such as sleep, recovery, and inflammation management. Hemp protein and fiber extracts support the clean-label nutrition trend, while terpenes and flavonoids gain traction as functional additives with enhanced aroma, antioxidant potency, and formulation flexibility across food and cosmetic industries.

Growth across all hemp ingredient types is heavily influenced by advancements in biotechnology, precision fermentation, and high-yield crop genetics that improve purity, consistency, and scalability. Producers are increasingly focused on minor cannabinoids as they offer high-margin innovation opportunities and diversified therapeutic profiles. Meanwhile, hemp-based proteins meet rising plant-based nutrition demand, and fiber extracts support sustainable material manufacturing. Regulatory clarity, product standardization, and expanding clinical validation continue to boost interest across both established cannabinoids and emerging bioactive compounds.

BY SOURCE:

By source, organic hemp leads the market as consumers and manufacturers prioritize clean-label, chemical-free, and eco-friendly ingredients. Organic cultivation aligns with evolving regulatory preferences and supports premium pricing structures, especially within nutraceuticals and cosmetics. Conventional hemp remains significant due to its widespread availability and lower production costs, making it ideal for large-volume industrial and food applications. GMO-free hemp maintains appeal for markets emphasizing purity, safety, and natural origin, especially in regions with strict labeling requirements.

Industrial hemp contributes strongly to the segment because of its versatility and high biomass yield, supplying raw materials for both bioactive extraction and fiber-based applications. Dominant factors influencing source selection include sustainability standards, soil health requirements, input-cost optimization, and regional agricultural regulations. Advancements in seed genetics, pest-resistant strains, and climate-tolerant crops further improve supply stability. Market demand increasingly favors transparency, traceability, and certified-growing practices, boosting the relevance of organic and GMO-free systems across premium product categories.

BY EXTRACTION PROCESS:

CO₂ extraction dominates due to its ability to produce high-purity cannabinoids with minimal residue, making it ideal for pharmaceuticals and high-end wellness products. Ethanol extraction retains strong adoption for its cost-efficiency and scalability, supporting mass-market formulations. Hydrocarbon extraction is still used for specific terpene-rich products but faces regulatory and safety challenges. The shift toward solvent-free methods reflects consumer demand for clean, chemical-free processing, especially in premium cosmetic and food-grade applications.

Enzyme-assisted extraction is growing rapidly as biotechnology enables targeted molecule release, enhanced yields, and reduced processing degradation. Dominant factors shaping extraction choices include purity requirements, operational safety, cost efficiency, and the desired concentration of active compounds. Regulatory frameworks increasingly favor solvent-free and eco-friendly extraction systems. Manufacturers also prioritize methods that enhance bioavailability and product consistency, pushing the market toward innovative and sustainable extraction technologies supported by automation and process optimization strategies.

BY FORM:

Oils hold the largest share due to their ease of formulation, broad application versatility, and consumer familiarity, particularly in wellness and skincare products. Isolates and distillates are widely used in pharmaceuticals and nutraceuticals where precision, purity, and consistent potency are essential. Powders gain traction in sports nutrition and functional foods for their stability and easy mixing. Capsules appeal to regulated health markets because of their accurate dosing, compliance benefits, and strong consumer trust in supplement formats.

Liquid concentrates are increasingly adopted by beverage, cosmetic, and industrial manufacturers seeking customizable, high-strength ingredient formats. Dominant factors influencing form selection include bioavailability, formulation demands, shelf-stability, regulatory classification, and consumer preference trends. Biotechnology advancements enable highly refined isolates and innovative delivery systems, improving functionality across applications. As demand for consistent, high-potency hemp ingredients grows, manufacturers prioritize forms that support scalability, precision dosing, and diversified product development.

BY APPLICATION:

The food & beverage and nutraceutical sectors lead application growth due to increasing demand for plant-based, functional, and wellness-enhancing ingredients. Pharmaceuticals continue to expand as clinical research validates cannabinoid efficacy in pain, neurological, and inflammatory treatments. In personal care and cosmetics, hemp-derived oils, terpenes, and proteins support anti-aging, hydration, and skin-repair formulations, driving strong adoption among premium skincare brands. The wellness industry’s shift toward natural actives significantly supports cross-category growth.

Animal nutrition benefits from hemp protein and fiber’s digestibility and clean nutritional profile, contributing to its rising integration in feed formulations. Industrial applications leverage hemp fibers and extracts for biodegradable materials, textiles, adhesives, and bio-based composites. Dominant growth factors include regulatory approval, expanding R&D, consumer health awareness, and rising interest in sustainable materials. As biotechnology boosts ingredient purity and functionality, applications broaden across therapeutic, nutritional, cosmetic, and industrial sectors.

BY DISTRIBUTION CHANNEL:

B2B dominates distribution due to its role in supplying manufacturers across pharmaceuticals, cosmetics, and nutraceuticals with bulk ingredients. This channel benefits from long-term supply contracts, quality assurance requirements, and diverse industrial applications. B2C continues growing through branded consumer products, especially in wellness and skincare categories. Online retail strengthens market reach by offering convenience, broader product visibility, and direct-to-consumer education about hemp benefits, ultimately supporting rapid adoption across global markets.

Specialty stores maintain significance by offering curated, high-quality hemp products supported by informed staff and targeted consumer engagement. Pharmacies are expanding as regulatory frameworks evolve, enabling the sale of medically aligned or clinically validated hemp ingredients. Dominant factors influencing channel preference include regulatory restrictions, brand positioning, consumer trust, and product quality transparency. Digital transformation and e-commerce integration continue reshaping distribution, supporting both mass-market accessibility and premium niche product strategies.

BY END USER:

Food manufacturers represent a major end-user segment due to rising demand for plant-based proteins, functional ingredients, and clean-label additives. Cosmetic and personal care brands increasingly integrate hemp extracts for anti-inflammatory and antioxidant benefits, driving product innovation in skincare, haircare, and wellness categories. Pharmaceutical companies adopt hemp-derived actives for their therapeutic potential, reinforcing demand for high-purity, standardized biotech ingredients that meet clinical-grade specifications and regulatory compliance expectations.

Nutraceutical companies leverage hemp cannabinoids, terpenes, and proteins to create supplements targeting immunity, stress relief, energy, and overall wellness. Research institutes play a crucial role by advancing biotechnology, fermentation-based cannabinoid production, and clinical validation, accelerating industry development. Dominant factors influencing end-user demand include formulation needs, purity standards, clinical evidence, evolving consumer preferences, and regulatory frameworks. As biotechnology enhances consistency and scalability, adoption increases across both commercial manufacturers and scientific institutions.

REGIONAL ANALYSIS:

The global market for biotech hemp ingredients is demonstrating robust growth as manufacturers actively seek consistent, sustainable, and scalable sources of cannabinoids. Companies are now leveraging advanced biosynthesis and fermentation processes to produce high-purity hemp compounds, effectively overcoming the agricultural challenges and regulatory inconsistencies associated with traditional cultivation. This technological shift is attracting significant investment from major sectors, including pharmaceuticals, cosmetics, and nutraceuticals, who require reliable and standardized ingredients for their product formulations.

Regionally, North America and Europe currently lead in both research and adoption, with a mature consumer base and progressive regulatory frameworks driving market expansion. Meanwhile, the Asia Pacific region is rapidly emerging as a powerhouse for manufacturing and a potential consumer market, as local governments begin to clarify their stance on hemp-derived products. Latin America and the Middle East & Africa are also developing their market presence, with specific countries exploring the economic potential of these innovative ingredients for both export and domestic applications.

MERGERS & ACQUISITIONS:

• In Jan 2024: Cronos Group launched a novel fermentation-derived cannabinoid, CBG, scaling production to meet demand for non-psychoactive ingredients in wellness and cosmetic formulations.
• In Apr 2024: Amyris successfully restructured, focusing its precision fermentation platform on high-value, sustainable cannabinoids to secure new partnerships in the personal care market.
• In Jul 2024: Ginkgo Bioworks expanded its cell-free bioconversion platform, enabling partners to efficiently produce rare cannabinoids with greater purity and at a lower cost.
• In Oct 2024: Octarine Bio secured Series B funding to advance its biosynthetic platform for producing complex cannabinoid derivatives targeted at the pharmaceutical industry.
• In Jan 2025: Willow Biosciences announced a major supply agreement with a global CPG company, marking a significant commercial-scale adoption of its bio-based cannabigerol (CBG).

KEY PLAYERS ANALYSIS

• Amyris, Inc.
• Cronos Group Inc.
• Ginkgo Bioworks
• Willow Biosciences Inc.
• Octarine Bio
• Teewinot Life Sciences
• Creo Inc.
• Hyasynth Biologicals
• Renew Biopharma
• LAVVAN Inc.
• Farmako GmbH
• Bioverbis (formerly known as Librede)
• CB Therapeutics
• Joyn Bio (a Bayer/Ginkgo venture)
• ZeaKal Inc.
• Canopy Growth Corporation
• Organigram Holdings Inc.
• Charlotte's Web, Inc.
• CV Sciences, Inc.
• Ecofibre Limited